Back to RIGL Stock Lookup

Rigel Pharma (RIGL) – Corporate News

Aug 13, 2014 07:33 AM Rigel Pharma (RIGL) Reports R348 Did Not Meet Endpoints in Ph-2 Dry Eye Study
Jul 16, 2014 07:35 AM Rigel Pharma (RIGL) Initiates Fostamatinib Phase 3
Oct 24, 2013 07:34 AM Rigel Pharma (RIGL) Reports R333 Missed Primary Endpoint, Will Cancel Development
Aug 26, 2013 07:30 AM Rigel Pharma (RIGL) Reports R343 Missed Primary Endpoint in Phase 2
Jun 4, 2013 06:37 AM AstraZeneca (AZN) Will Not Proceed with Fostamatinib; Returns Rights to Rigel (RIGL)
May 22, 2013 07:34 AM Rigel Pharma (RIGL) Advances R348 to Phase 2
Apr 5, 2013 06:32 AM AstraZeneca (AZN) Reports Statistically Significant Data from OSKIRA-1
Dec 13, 2012 07:37 AM AstraZeneca (AZN) Updates on OSKIRA-4 Top-Line Results; Did Not Meet Secondary Objective
Oct 3, 2012 09:30 AM Rigel (RIGL) Affirms Pricing 13.7M Offering at $9.50/Share
Oct 3, 2012 08:42 AM Rigel Pharma (RIGL) Said to Price 13.7M Common Offering at $9.50/Share
Jun 19, 2012 08:27 AM AstraZeneca (AZN), Rigel (RIGL) in Exclusive License Agreement for JAK Inhibitor R256
May 26, 2011 09:02 AM Rigel Pharma (RIGL) Prices 16.3M Common Offering at 5.8% Discount
May 6, 2011 07:37 AM Rigel Pharma (RIGL) to Commence Development of R343
Sep 29, 2010 07:49 AM Rigel Pharma (RIGL) Receives $25M From AstraZeneca (AZN) for the Achievement of Two Major Milestones in R788 Development
Sep 22, 2010 05:11 PM AstraZeneca (AZN) Announces Positive Data from Fostamatinib in Patients with RA Who Didn't Respond to MTX
Mar 29, 2010 07:41 AM Rigel Pharma (RIGL) Announces Expiration of HSR Act for License Agreement with AstraZeneca (AZN)
Feb 16, 2010 07:43 AM AstraZeneca (AZN) and Rigel Pharma (RIGL) Announces Fostamatinib Disodium Development Collaboration
Dec 23, 2009 07:41 AM Rigel Pharma (RIGL) Receives Milestone Payment as Part of Cancer Treatment Collaboration
Jul 9, 2009 07:51 AM Rigel's (RIGL) R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
Dec 8, 2008 09:17 AM Rigel Pharma (RIGL) Reports Results from Phase 2 Trial of R788

Back to RIGL Stock Lookup